Clinical Trials NZ

16/02/2026

Do you live with moderate-to-severe Atopic Dermatitis that’s affecting your quality of life?

A new clinical study is now enrolling adults to investigate the safety and effectiveness of an investigational medication for moderate-to-severe Atopic Dermatitis. This treatment may help relieve symptoms such as persistent itching, inflammation, and flare-ups.

You may be eligible if you:
• Are aged 18 years or older
• Have had a doctor’s diagnosis of chronic Atopic Dermatitis for at least 12 months
• Have had an inadequate response to topical corticosteroids or calcineurin inhibitors within the past 3 months

By taking part, you’re not only exploring a potential new treatment - you’re also helping advance research for others living with Atopic Dermatitis.

For more info on this study contact us.

10/12/2025

Clinical Trials NZ Christmas lunch at Gothenburg restaurant in Hamilton with Mary, Rakesh, Lenka, Angela, Renu, Eileen, Andrea and Noeleen.

Lots of fun, beautiful food and everyone enjoyed themselves after a busy and productive year with our achievements with the clinical trials.

08/12/2025

Clinical Trials NZ warmly welcomed representatives from Attovia Therapeutics (Sponsor ) and Indero (CRO) for an exciting new Atopic Dermatitis study commencing in 2026.

We look forward to collaborating with them on this study and sincerely hope this marks the beginning of a long and productive partnership.

24/11/2025

Clinical Trials New Zealand were delighted to be present at the Aortic Symposium, sponsored by Gore.

Dr Manar Khashram presented ongoing Aortic Clinical Trials conducted in partnership with CTNZ — research that sits at the forefront of vascular innovation in Aotearoa.

Team pictured (right to left):
Rakesh Aher RC, Lenka Feisst RC, Dr Manar Khashram, Professor Greg Jones, Eileen Bisley MD CTNZ, and Noeleen Cairns RC.

12/08/2025

Clinical Trials New Zealand (CTNZ) has an excellent and well-known international reputation for providing high-quality data. The unit has performed a wide range of studies from Phase II to post-marketing studies, including post-operative medical device studies and numerous pharmacokinetic studies.
https://www.clinicaltrialsnz.com/about-us

04/12/2023

Our vascular surgeon Dr Manar Khashram has been awarded the winner of the Kudos Awards Te Whatu Ora Waikato Medical Scientist Award Category in 2023. One of the most prominent trials conducted by CTNZ include the management of abdominal aortic aneurysms.
https://www.clinicaltrialsnz.com/article/dr-manar-khashram-awarded-a-kudos-award

The Kudos Science Trust - Kudos Awards

10/07/2023

Clinical Trials NZ runs both sponsor lead and investigator lead clinical trials, through public and private facilities within Hamilton, New Zealand. Clinical Trials NZ is dedicated to providing exceptional care to our patients, while collecting exemplary data.
https://www.clinicaltrialsnz.com/sponsorscros

23/05/2023

Our sightseeing time after the IM meeting in Tokyo. At the top of the Tokyo tower.
From the left Eileen, Sarah, Sharon & Alana.

03/05/2023

Our Clinical Trials NZ vascular team has been conducting Prevision study with PI Dr Manar Khashram.
https://www.clinicaltrialsnz.com/article/prevision-study-with-pi-dr-manar-khashram

02/05/2023

Clinical Trials NZ staff member Mrs Neerja Singh is one of the finalist of Haut Monde Mrs India Worldwide Pageant 2023.

16/01/2023

One of the drugs we are using in our Atopic Dermatitis trial.

New page — Nemolizumab: a biological therapy used to treat moderate to severe prurigo nodularis and atopic dermatitis. Read more: http://ow.ly/gjL650MnifE

16/01/2023

A pilot randomised controlled trial of oral doxycycline after endoscopic sinus surgery and its effects on the sinonasal microbiome.

https://www.clinicaltrialsnz.com/article/a-pilot-randomised-controlled-trial-of-oral-doxycycline-after-endoscopic-sinus-surgery-and-its-effects-on-the-sinonasal-microbiome